Clinical Trial

A Clinical Study of T3011 in Subjects With Advanced Melanoma

Name: A Clinical Study of T3011 in Subjects With Advanced Melanoma — clinical trial record (NCT06214156)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

This clinical study evaluated the tolerability, safety and preliminary efficacy of T3011 in subjects with advanced melanoma.

Protocol Amendment History 6 amendments

This ClinicalTrials.gov record has been amended 6 times since 2024-01-09; most recent amendment 2026-01-12.

Status change: Not Yet Recruiting → Recruiting 2024-01-30

Trial Details

NCT Number	NCT06214156
Lead Sponsor	Shanghai Pharmaceuticals Holding Co., Ltd
Conditions	Advanced Melanoma
Enrollment	42 participants
Start Date	2024-01-26
Primary Completion	2026-09-30 (estimated)
Study Completion	2026-09-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-06